COM:ADMABIOLOGICS
ADMA Biologics, Inc.
- Stock
Last Close
21.37
21/11 21:00
Market Cap
2.78B
Beta: -
Volume Today
2.00M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -15.53M - | -16.81M 8.28% | -17.97M 6.88% | -19.52M 8.60% | -43.76M 124.23% | -65.74M 50.24% | -48.28M 26.56% | -75.75M 56.90% | -71.65M 5.41% | -65.90M 8.02% | -28.24M 57.15% | |
depreciation and amortization | 210.63K - | 247.85K 17.67% | 469.82K 89.56% | 469.58K 0.05% | 2.69M 473.35% | 3.45M 28.01% | 3.26M 5.46% | 3.94M 21.00% | 5.50M 39.40% | 7.11M 29.44% | 8.33M 17.13% | |
deferred income tax | -43.29K - | 74.36K 271.76% | 651.24K 775.84% | 1.88M - | 122.19K 93.49% | -1.36M 1,211.27% | -910.10K 32.98% | 220.76K 124.26% | 17.70M - | |||
stock based compensation | 888.29K - | 1.25M 40.54% | 1.71M 37.05% | 1.25M 26.94% | 1.56M 24.93% | 2.22M 42.37% | 2.65M 19.23% | 2.86M 7.71% | 3.49M 22.18% | 5.21M 49.49% | 6.19M 18.65% | |
change in working capital | 3.44M - | 177.93K 94.82% | -671.12K 477.18% | -1.01M 50.13% | -282.24K 71.99% | -3.69M 1,206.84% | -33.50M 808.32% | -33.78M 0.83% | -51.68M 52.99% | -18.29M 64.62% | -10.12M 44.64% | |
accounts receivables | 39.11K - | -383.96K 1,081.70% | -540.51K 40.77% | -93.56K 82.69% | -2.86M 2,959.17% | 2.49M 186.92% | -2.08M 183.51% | -9.77M 370.16% | -15.34M 57.05% | 13.07M 185.22% | -11.92M 191.16% | |
inventory | -403.46K - | -39.70K 90.16% | -1.74M 4,274.90% | -1.57M 9.36% | 589.32K 137.43% | -5.99M 1,116.09% | -34.65M 478.66% | -28.47M 17.83% | -43.19M 51.69% | -38.56M 10.73% | -9.63M 75.03% | |
accounts payables | 1.61M - | -937.78K 158.28% | 308.66K 132.91% | 476.83K 54.48% | 2.81M 489.75% | -20.48K 100.73% | 3.27M 16,087.30% | 1.90M 42.00% | 1.36M 28.61% | 799.98K 40.99% | 3.84M 379.89% | |
other working capital | 2.19M - | 1.54M 29.80% | 1.30M 15.70% | 183.53K 85.86% | -821.50K 547.62% | -167.69K 79.59% | -49.36K 70.56% | 2.56M 5,281.83% | 5.49M 114.71% | 6.40M 16.51% | 7.58M 18.46% | |
other non cash items | 146.87K - | 359.66K 144.89% | 390.54K 8.58% | 534.11K 36.76% | 638.73K 19.59% | 961.33K 50.51% | 1.04M 7.93% | 1.64M 58.03% | 1.75M 7.01% | 12.35M 604.06% | 14.94M 20.94% | |
net cash provided by operating activities | -10.89M - | -14.70M 35.07% | -15.42M 4.85% | -18.27M 18.49% | -37.27M 104.02% | -62.68M 68.17% | -76.19M 21.56% | -102.00M 33.87% | -112.37M 10.16% | -59.51M 47.04% | 8.80M 114.79% | |
investments in property plant and equipment | -196.63K - | -2.32M 1,081.50% | -26.07K 98.88% | -73.41K 181.56% | -2.68M 3,545.73% | -2.10M 21.70% | -3.81M 81.90% | -12.73M 233.87% | -13.51M 6.16% | -13.91M 2.96% | -4.98M 64.19% | |
acquisitions net | 12.50M - | 2K - | ||||||||||
purchases of investments | -2.94M - | -1.72M 41.49% | -1.72M 0.12% | -15.68M 814.02% | -12.50M 20.28% | |||||||
sales maturities of investments | 16.66M - | 5.39M 67.64% | ||||||||||
other investing activites | 12.50M - | |||||||||||
net cash used for investing activites | -3.13M - | -4.04M 29.02% | -1.74M 56.90% | 904.58K 151.94% | 15.21M 1,581.86% | -2.10M 113.77% | -3.81M 81.90% | -12.72M 233.82% | -13.51M 6.18% | -13.91M 2.96% | -4.98M 64.19% | |
debt repayment | -11.57K - | -12.65K 9.38% | -15.31M 120,925.94% | -15.14K 99.90% | -20.02M 132,118.50% | -36.28K 99.82% | -30.03M 82,677.39% | -13.98M 53.44% | -34.30K 99.75% | -100.04M 291,560.64% | -38.68M 61.34% | |
common stock issued | 27.03M - | 10.26M - | 14.14M 37.90% | 39.20M 177.13% | 42.94M 9.55% | 48.40M 12.70% | 131.20M 171.08% | 121.14M 7.66% | 64.65M 46.64% | 1.10M 98.29% | ||
common stock repurchased | -61.60K - | -2.90M 4,606.06% | ||||||||||
dividends paid | -61.60K - | -2.90M 4,606.06% | ||||||||||
other financing activites | 613.53K - | 9.81M 1,498.60% | 15.46M 57.62% | 2.71M 82.48% | 41.57M 1,434.74% | 13.01K 99.97% | 61.64M 473,764.23% | 26.68M 56.71% | 61.60K 99.77% | 150.04M 243,480.84% | -1.42M 100.94% | |
net cash used provided by financing activities | 27.63M - | 9.80M 64.55% | 10.40M 6.19% | 16.84M 61.88% | 60.75M 260.79% | 42.92M 29.35% | 80.00M 86.39% | 143.90M 79.86% | 121.05M 15.88% | 108.85M 10.08% | -38.99M 135.82% | |
effect of forex changes on cash | 458 - | |||||||||||
net change in cash | 13.61M - | -8.95M 165.75% | -6.76M 24.49% | -526.09K 92.22% | 38.69M 7,454.74% | -21.85M 156.48% | -2.72K 99.99% | 29.17M 1,073,674.42% | -4.83M 116.57% | 35.43M 833.28% | -35.17M 199.26% | |
cash at beginning of period | 12.54M - | 26.15M 108.60% | 17.20M 34.23% | 10.44M 39.29% | 9.91M 5.04% | 48.61M 390.25% | 26.75M 44.96% | 26.75M 0.01% | 55.92M 109.03% | 51.09M 8.64% | 86.52M 69.35% | |
cash at end of period | 26.15M - | 17.20M 34.23% | 10.44M 39.29% | 9.91M 5.04% | 48.61M 390.25% | 26.75M 44.96% | 26.75M 0.01% | 55.92M 109.03% | 51.09M 8.64% | 86.52M 69.35% | 51.35M 40.65% | |
operating cash flow | -10.89M - | -14.70M 35.07% | -15.42M 4.85% | -18.27M 18.49% | -37.27M 104.02% | -62.68M 68.17% | -76.19M 21.56% | -102.00M 33.87% | -112.37M 10.16% | -59.51M 47.04% | 8.80M 114.79% | |
capital expenditure | -196.63K - | -2.32M 1,081.50% | -26.07K 98.88% | -73.41K 181.56% | -2.68M 3,545.73% | -2.10M 21.70% | -3.81M 81.90% | -12.73M 233.87% | -13.51M 6.16% | -13.91M 2.96% | -4.98M 64.19% | |
free cash flow | -11.08M - | -17.03M 53.63% | -15.44M 9.30% | -18.34M 18.76% | -39.95M 117.79% | -64.77M 62.15% | -80.01M 23.51% | -114.73M 43.40% | -125.88M 9.72% | -73.42M 41.68% | 3.82M 105.20% |
All numbers in (except ratios and percentages)